NorthWest EHealth (NWEH) is proud to announce its remarkable achievement of winning three prestigious awards at the 2025 Pharmaceutical Technology Excellence Awards. Recognised in the categories of Innovation, Safety, and Diversity, NWEH has demonstrated its commitment to transforming clinical trial processes through its cutting-edge platforms, ConneXon and FARSITE.
The Pharmaceutical Technology Excellence Awards celebrate outstanding achievements across the pharmaceutical industry, evaluating companies based on a rigorous methodology that includes case study submissions, research, editorial evaluation, and market data.
“These awards highlight our dedication to bring market leading enhancements to our ConneXon and FARSITE Platforms. They are a testament to our continued impact, and the hard work and dedication from our team over the last year. Their commitment to transforming health data into meaningful insights that drive better patient outcomes, improve research efficiency, and promote diversity in clinical trials, is second to none. As we look to the future, we will continue to push the boundaries of data-driven healthcare innovation.”
– Jonathan Wogel, CEO, NWEH